key: cord-0799770-4rb9zar1 authors: Hall, Rosie; Harvey, Mary Rose; Patel, Vinod title: Diabetes care in the time of COVID‐19: video consultation as a means of diabetes management date: 2022-04-05 journal: Practical Diabetes DOI: 10.1002/pdi.2387 sha: 4bf420f5a180002c0e7217686afc9aca619454d0 doc_id: 799770 cord_uid: 4rb9zar1 Background: This review specifically focuses on the use of video consultation in diabetes management, in comparison to standard care. The population of chronic condition sufferers in the UK is considerable and teleconsultation use has, in recent years, been explored. COVID‐19 has created an additional pressure on health services to use teleconsultation. Diabetes mellitus affects approximately four million people in the UK. If clinical outcomes are uncompromised, the benefits of using a remote service could encourage the use of video consultation for diabetes management in normal practice. Aims: A systematic review of the use of video consultation in place of standard consultation in the management of diabetes mellitus. Both clinical and non‐clinical outcomes are reviewed, in addition to patient satisfaction levels after using video consultation. Methods: A systematic literature search was conducted to select published articles from web‐based health databases. Data extraction and analysis of results followed. Results: Twelve studies were selected. Overall, the clinical outcomes (HbA(1c), low‐density lipoprotein levels and blood pressure) appeared to be uncompromised with the use of video consultation. Patient satisfaction was high, with few limitations found. The economic and time saving benefits of this approach proved to be additional advantages. Conclusions: Despite there being a lack of literature identified in this field, the results support the use of video consultation in diabetes management. The evidence suggests that this approach should be utilised in the time of COVID‐19 and beyond. Future research should assess the use of video consultation over a reasonable duration through randomised controlled trials. Copyright © 2022 John Wiley & Sons. The demand for eHealth is increasing in tandem with technology capabilities; 'eHealth is the use of information and communication technologies (ICT) for health.' 1 This includes telephone calls, video calls, texting or internet platforms aiming to educate patients on their condition and its management. Teleconsultation is defined as 'a general term for any consultation between doctors or between doctors and patients on a network or video link (e.g. Facetime, intranet, internet, Skype, etc.)'. 2 Private companies have offered GP video consultations to patients in the past; however, implementing teleconsultation within the NHS has been a slow process. 3 The recent COVID-19 pandemic has put pressure on the NHS to adopt teleconsultation as a method of primary health care in general practice wherever possible. [4] [5] [6] The prevalence of diabetes is estimated to be four million in the UK, with its management accounting for 10% of the annual NHS budget for England and Wales. 7 Without proper management and monitoring, uncontrolled diabetes can lead to further, avoidable, complications. 8 Once the disease is controlled, diabetes patients attend face-to-face follow-up appointments every three to 12 months. Lee et al. , and others, found that teleconsultation maintains the health care professionalpatient relationship, and continues to utilise evidence-based medicine to give the best care to the patient, while providing economic benefit to both the NHS and patient. [9] [10] [11] Remote medical consultations have proved to be beneficial in rural populations and for those unable to travel. 12 To date, ICT has been successful in the management of chronic conditions such as diabetes, stroke and Parkinson's disease. [13] [14] [15] [16] [17] The main limitations identified were lack of access to a smart device/internet, and usability of technology. However, the benefits seem to outweigh the limitations, and as technology is evolving so is its accessibility. Epidemiological data on the COVID-19 pandemic showed that patients comorbid with diabetes had an increased risk of in-hospital death due to COVID-19. 18 It is important to note that this could be due to common comorbidities in patients with diabetes, such as obesity. Never theless, these data highlighted the importance of taking measures to limit contact between these patients and health care professionals where possible, which further advocates for the use of video consultation. A comparison is yet to be made between the benefit of using video consultation compared to conventional management of diabetes, which is usually face-to-face consultation. Video consultation is defined by the NHS as a process 'where you speak to a doctor or health care professional using the video camera in your smartphone, tablet or computer'. 19 This systematic review aims to assess the use of video consultation vs conventional face-to-face consultation in the management of diabetes mellitus, by examining both clinical outcomes and patient satisfaction levels. The PICO (Population, Intervention, Comparison and Outcome) method of formulating a research question and framing eligibility criteria was used to address research aims. The population to be studied was patients with diabetes mellitus type 1 or 2, using an intervention of video consultation in comparison to conventional management. Comparison to conventional management in this study means studies using data from face-to-face appointments, or patient baseline data before intervention can be included. HbA1c levels, lowdensity lipoprotein (LDL) cholesterol level and blood pressure (BP) are primarily monitored in patients with diabetes. The PRISMA study selection tool was used. 20 An electronic database search was conducted, and duplicate articles were removed from the results. Titles and abstracts were read by two independent reviewers, and inclusion and exclusion criteria detailed in Table 1 were used to remove further articles. The remaining articles were read in full text and removed if deemed outside of the inclusion criteria. Twelve articles were eligible for inclusion in the review. A PRISMA flowchart was created to summarise the process of study selection ( Figure 1 ). Structured searches were conducted on four electronic databases: Medline, Embase, Web of Science and CINAHL in May 2020. Key word search terms included video consultation, videoconferencing, video appointment, remote consultation, telemedicine, teleconsultation, m-health, face-toface consultation, diabetes mellitus, type 1 diabetes, and type 2 diabetes. These were used to search for both qualitative and quantitative publications between the years 2010-2020, using Boolean operators. The search parameters were set between these years as the use of teleconsultation is a relatively recent field, and grey literature was not searched due to infancy of this field. Research papers which were literature reviews, letters or comments were also excluded, as these did not contain the raw data for a narrative synthesis of results. The common outcomes identified were patient HbA1c level, LDL cholesterol levels, BP, and patient satisfaction. Secondary outcomes such as cost were also explored. Searches were completed on 1 August 2021. The CASP tool was used to critically appraise selected articles, to assess bias and eligibility. 21 Different CASP checklists were used to review different study designs. As a literature review, ethical approval was not necessary. A total of 4263 records were found in the initial database search, 2170 of which were found to be duplicates, which left 2093 unique articles. Only online databases were searched, due to the infancy of this intervention in diabetes care. Titles and abstracts were screened for exclusion and inclusion criteria for eligibility; 2039 articles were excluded at this stage. Fifty-four published papers were then read in full text for eligibility, at which point 42 further articles were excluded. A final 12 articles were included in the review (Figure 1 ). CASP checklists were used to assess bias and eligibility for the 12 studies selected for inclusion. There were a number of studies included which compared intervention values to baseline values instead of a control group with significant improvements, and therefore these data should be considered in a sceptical manner. For example, there is known variation in reported BP, due to human error or device used. Of the seven studies which reported patient perspective, all concluded that the use of video consultation was a positive experience, despite limitations. Veteran populations were able to adjust to the use of technology with sufficient ease, and the standard of care across both methods was found to be uncompromised. The main limitations reported were forming a relationship with the health care provider and difficulty in performing full physical examinations, although the latter was attempted by using 'zoom' features during video consultation. Other studies had nurses or other health care professionals in the room with the patient to complete these, while the specialist consultant was remote. Crossen et al. found that 94% of patients completing their study found they were 'very satisfied' with the video visit experience. 26 As expected, an estimated reduction of US$60-70 in travel costs per consultation was reported, and a reduced duration of time was taken out of work to attend appointments. According to Levin et al., the average video appointment requires patients to take approximately 1 hour out of their working day. 27 Bertuzzi et al. also reported reduced travel time by approximately 5 hours, a reduction in travel costs by an average of €80 per visit, and 115 minutes of time saved per video consultation. The latter is most likely due to reduced waiting times. 32 Overall, the studies showed that, with video consultation management, HbA1c levels appeared to be uncompromised over time. This is a positive finding, and important since HbA1c level can be used diagnostically for diabetes. 34 Diabetes is typically associated with raised LDL levels; results here suggest video consultation neither reduces nor raises LDL level. 35 Blood pressure is monitored in patients with diabetes as hypertension increases the risk of stroke or myocardial infarction. 36 In all studies reporting BP, it was either maintained or lowered with the use of video consultation. Improvement or maintenance of these outcomes are an important part of any diabetes treatment. With no detriment to HbA1c, LDL and BP, these findings further support the use of video consultation as a safe and effective method of delivering diabetes care. The economic benefit and time saving in consultation and travel are significant. This is beneficial for both the health care provider and the patient. Since there is a high percentage of the population with diabetes, implementing video consultation could be of considerable economic benefit for the NHS. 35 Still, the main obstacle to overcome in full-scale implementation of video consultation is patient satisfaction. If patients are unreceptive to the service, it presents major challenges to its application. In this review of literature, few limitations were found by patients. An overwhelming majority of patients would use video consultation again. 32 Even in older populations, where technological aptitude presents more of a challenge, the general findings indicate a positive experience. In previous literature, the importance of implementing teleconsultation or eHealth within the correct window for each patient is highlighted. 37 The optimum intervention time for use of video consultation in diabetes management is to be established. However, once stability of clinical outcomes is reached and once a health care professional-patient relationship has been formed, use of video consultation for follow-up appointments would be most appropriate. It would be feasible to use video consultation for follow-up appointments, and continue use of face-toface appointments for certain physical examinations such as monitoring diabetic retinopathy, although some of these would be able to be done remotely, such as most of a foot examination. Practically, training for both patient and health care professional would be needed, in addition to access to appropriate equipment. One strength of this review is that solely the use of video consultation under the umbrella term of teleconsultation is examined, and this has not been explored previously. In addition, both quantitative and patient perspective outcomes were reported, which creates a more well-rounded report relevant to clinical practice. There were limitations to the studies selected for this review. An improvement in HbA1c in type 2 diabetes mellitus could be due to introduction or modification of insulin. Additionally, the lack of a predefined control group in some studies meant that baseline data from either national databases or the patient's previous medical record were used. This is made clear for each study in Appendix 2 for comparison groups. These data were used for comparison to data collected after video consultation intervention. This could introduce confounding variables and as such the results of this study must be interpreted cautiously. Some patient populations were predominantly male, younger or older, which may make the results less applicable to wider populations. Finally, the duration of studies varied between one video consultation and five years of video consultation use, and some studies had a small sample size due to the infancy of this field. This review has its own limitations. It includes four pilot studies which generally test feasibility of the use of the video consultation model, rather than concentrating on patient outcomes. However, the decision to include these was carefully considered, and the benefit of these articles to add weight to this review outweighed any hesitations -particularly as there were few studies selected due to the recent introduction of this intervention in diabetes care. In addition, 12 studies were selected for review, and widening search terms could make a more robust review. In the future, exploring other forms of telecare use in diabetes, rather than confining results to the use of video consultation, would expand this evolving field of research. In addition, studies exclusively reporting type 1 diabetes mellitus patient data would be useful in determining whether improvement of HbA1c was due to video consultation, or medication. Future studies should assess larger sample sizes for a longer duration of time in order to obtain more accurate results. The need for further evidence of the impact of teleconsultation on diabetes patients' outcomes is apparent. The COVID-19 virus provides a unique opportunity to study video consultation. 38 Use of a standardised checklist such as the Alphabet strategy for diabetes consultation would allow patient education and timely multidisciplinary team intervention. 39 It would be useful to study the use of a remote consultation strategy such as this as a viable standardised tool to use during teleconsultation during the COVID-19 pandemic and in the future. It is feasible to use video consultation in the place of conventional consultation in clinical practice for the treatment of diabetes. Implement ation may take some time, with training required for both patients and health care professionals. However, the economic and time saving advantages of video consultation, in addition to having clinical outcomes similar to those of conventional management, make for a convenient method of diabetes management. There are no conflicts of interest declared. • The pressure on health services caused by the COVID-19 pandemic has meant means of chronic disease management, such as video consultation, have been implemented • This review compares clinical outcomes and patient satisfaction levels between video consultation and standard management of diabetes mellitus • Clinical outcomes (HbA1c, low-density lipoprotein levels, blood pressure) appeared to be uncompromised over time • Patient satisfaction of video consultation use was high, with few limitations found • The results support the use of video consultation in clinical practice for the treatment of diabetes, both during the pandemic and beyond Teleconsultation -TheFreeDictionary Medical Dictionary Alternatives to the face-to-face consultation in general practice: focused ethnographic case study The use of telemedicine during COVID-19 pandemic Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis COVID-19 and diabetes: Knowledge in progress Diabetes: The Basics Diabetes/kidney/heart disease Patient satisfaction with virtual obstetric care. Matern Child Health Telemedicine cost-effectiveness for diabetes management: A systematic review The cost-effectiveness of digital health interventions on the management of cardiovascular diseases: Systematic review Delivering occupational therapy hand assessment and treatment sessions via telehealth Agreement between face-toface and tele-assessment of upper limb functioning in patients with Parkinson disease How will telemedicine change clinical practice in chronic obstructive pulmonary disease? eHealth as the next-generation perinatal care: An overview of the literature Telemedicine for Parkinson's disease: Limited engagement between local clinicians and remote specialists Digital health for COPD care: the current state of play Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study NHS. 2020. Video Consultations The PRISMA 2020 statement: an updated guideline for reporting systematic reviews CASP Checklist I'm Not Feeling Like I'm Part of the Conversation" Patients' perspectives on communicating in clinical video telehealth visits A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study The utilization of video-conference shared medical appointments in rural diabetes care 37c PRACTICAL DIABETES